Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

LEO Pharma reports outcomes from Phase IIb trial of atopic dermatitis therapy
Clinical Trials Arena
Monday, May 12, 2025 - 9:52pm
tags:
LEO Pharma, clinical trials, temtokibart, atopic dermatitis
Roche plans $700m manufacturing plant in the US
Yahoo Finance
Monday, May 12, 2025 - 9:49pm
tags:
Roche, drug manufacturing, obesity
Trump revives ‘most favored nation’ plan in effort to cut US drug prices
BioPharma Dive
Monday, May 12, 2025 - 12:06pm
tags:
Donald Trump, drug pricing, most favored nation
Lexeo laid off 15% of staff in April to focus on lead cardiac gene therapies
Fierce Biotech
Monday, May 12, 2025 - 12:05pm
tags:
Lexeo Therapeutics, layoffs, gene therapy
FDA, CDC call for pause of chikungunya shot rollout in older adults
Fierce Pharma
Monday, May 12, 2025 - 12:02pm
tags:
FDA, CDC, chikungunya virus, vaccines, Valneva
Dynavax's feud with activist investor heats up ahead of annual meeting
Fierce Biotech
Monday, May 12, 2025 - 12:00pm
tags:
Dynavax, Deep Track Capital, activist investors
Vir’s hepatitis B combo falls short in Phase II trial
Clinical Trials Arena
Monday, May 12, 2025 - 11:58am
tags:
Vir Biotechnology, clinical trials, hepatitis B
Novartis to keep making malaria drugs even if orders dry up, Reuters reports
Tip Ranks
Monday, May 12, 2025 - 11:39am
tags:
Novartis, malaria, leprosy
Pfizer partner RemeGen says HER2 ADC prolongs life in newly diagnosed bladder cancer
Fierce Pharma
Monday, May 12, 2025 - 11:36am
tags:
RemeGen, Pfizer, antibody-drug conjugates, clinical trials, bladder cancer
AI is already delivering pharma value — and not just in drug discovery
Pharma Voice
Monday, May 12, 2025 - 11:34am
tags:
artificial intelligence, drug discovery, Isomorphic Labs, Tempus AI, Insilico, Axiom Bio, clinical trials
UK approves AZ inhaler with 'greener' propellant
Pharmaphorum
Monday, May 12, 2025 - 11:30am
tags:
AstraZeneca, UK, Trixeo Aerosphere, inhalers, global warming
For cell therapies, raw material quality hinges on the human touch
Pharmaphorum
Monday, May 12, 2025 - 11:26am
tags:
cell therapy, drug manufacturing, raw materials, quality control
Trump says he will sign order aimed at cutting drug prices to match other countries
USA Today
Sunday, May 11, 2025 - 10:10pm
tags:
Donald Trump, most favored nation, drug pricing
Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial
Investing.com
Sunday, May 11, 2025 - 10:06pm
tags:
Eli Lilly, Zepbound, Novo Nordisk, Wegovy, clinical trials
Zevaskyn Gets FDA Nod as First Cell Therapy for Rare, Debilitating Skin Disease
Xtalks
Sunday, May 11, 2025 - 10:02pm
tags:
Abeona Therapeutics, zamikeracel, pz-cel, FDA, Zevaskyn, rare disease
The FDA approves first U.S. at-home tool as a Pap-smear alternative
NPR
Sunday, May 11, 2025 - 9:59pm
tags:
FDA, cervical cancer, Teal Health, Medtech, pap smears
FDA chief Martin Makary sets June deadline for genAI rollout
Clinical Trials Arena
Friday, May 9, 2025 - 9:41am
tags:
FDA, Marty Makary, artificial intelligence, genAI
FDA layoffs could slow safety communications, experts warn
BioPharma Dive
Friday, May 9, 2025 - 9:39am
tags:
FDA, regulatory, drug safety, layoffs, recalls
FDA misses another approval decision target date, this time for GSK's Nucala in COPD
Fierce Pharma
Friday, May 9, 2025 - 9:36am
tags:
FDA, HHS, GSK, COPD, Nucala, regulatory, drug approvals
4 more biotechs cut staff amid market tumult
BioPharma Dive
Friday, May 9, 2025 - 9:35am
tags:
Vor Bio, Korro Bio, Insitro, Rallybio, biotech, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.